Debut Secures $20M to Accelerate AI-based Skin Longevity Ingredient Discovery and Expand its Formulation Business in the US and Asia

SAN DIEGO, Aug. 26, 2025 /PRNewswire/ — Debut, a leader in biotech beauty, has raised $20M to expand its AI-based ingredient discovery platform. This funding aims to enhance skin longevity innovation and grow its formulation business in the US and Asia.

The investment will aid in discovering next-generation ingredients targeting aging and allow beauty brands to innovate with advanced biotech ingredients without heavy R&D costs. Debut’s platform screens over 50 billion ingredients to optimize skin health.

Founder and CEO Joshua Britton emphasized their focus on pioneering skin health through novel chemical entities. Debut’s in-house skin health datasets achieve 99% consistency, improving ingredient prediction capabilities.

As Debut enters the Asian market, starting in Singapore, they plan to partner with leading brands for custom longevity skincare solutions. This expansion is supported by investors including Fine Structure Ventures and L’Oréal’s BOLD.

Debut, recognized as one of the TIME100 Most Innovative Companies 2025, is committed to redefining beauty standards with scientifically-discovered and sustainable ingredients.

For more information, visit Debut Biotech.